Technical Analysis for RHHBY - Roche Hldg Ltd Spons
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 47.49 | 0.72% | 0.3400 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Historical RHHBY trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 0.72% | |
| Stochastic Buy Signal | Bullish | 0.72% | |
| Lower Bollinger Band Walk | Weakness | 0.72% | |
| Inside Day | Range Contraction | 0.72% | |
| Below Lower BB | Weakness | 0.72% | |
| Down 3 Days in a Row | Weakness | 0.72% | |
| Down 4 Days in a Row | Weakness | 0.72% | |
| Down 5 Days in a Row | Weakness | 0.72% | |
| Oversold Stochastic | Weakness | 0.72% | |
| 200 DMA Support | Bullish | -0.65% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Rose Above Lower Bollinger Band | about 1 hour ago |
| Rose Above Previous Day's High | about 1 hour ago |
| Up 1% | about 1 hour ago |
| 200 DMA Resistance | about 1 hour ago |
| Down 2 ATRs | 2 days ago |
Get a Trading Sidekick!
Roche Hldg Ltd Spons Description
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Life Sciences Pharmaceutical Products Diabetes Pharmaceutical Industry In China Immunology Infectious Diseases Disease Ophthalmology Neuroscience Molecular Diagnostics Nucleic Acid Gene Expression Pega Sequencing Avast Chugai Pharmaceutical Co. Diabetes Care Hoffmann La Roche Roche Diagnostics Division Genentech Pegasys Pharmaceuticals Division
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 52.47 |
| 52 Week Low | 39.8 |
| Average Volume | 887,680 |
| 200-Day Moving Average | 47.5599 |
| 50-Day Moving Average | 50.1541 |
| 20-Day Moving Average | 50.4010 |
| 10-Day Moving Average | 49.4410 |
| Average True Range | 0.8931 |
| ADX | 17.73 |
| +DI | 15.2960 |
| -DI | 39.1375 |
| Chandelier Exit (Long, 3 ATRs) | 49.7907 |
| Chandelier Exit (Short, 3 ATRs) | 49.3893 |
| Upper Bollinger Bands | 53.0735 |
| Lower Bollinger Band | 47.7285 |
| Percent B (%b) | -0.11 |
| BandWidth | 10.6049 |
| MACD Line | -0.6111 |
| MACD Signal Line | -0.2036 |
| MACD Histogram | -0.4076 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 48.1400 | ||||
| Resistance 3 (R3) | 48.1400 | 47.8100 | 47.9750 | ||
| Resistance 2 (R2) | 47.8100 | 47.5579 | 47.8100 | 47.9200 | |
| Resistance 1 (R1) | 47.4800 | 47.4021 | 47.3150 | 47.4800 | 47.8650 |
| Pivot Point | 47.1500 | 47.1500 | 47.0675 | 47.1500 | 47.1500 |
| Support 1 (S1) | 46.8200 | 46.8979 | 46.6550 | 46.8200 | 46.4350 |
| Support 2 (S2) | 46.4900 | 46.7421 | 46.4900 | 46.3800 | |
| Support 3 (S3) | 46.1600 | 46.4900 | 46.3250 | ||
| Support 4 (S4) | 46.1600 |
